Genes, Drugs and Stem Cells – Novel Therapies at Imperial College London - UCAS

Course options

There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Course summary

Gain proficiency in translational research and explore a range of next-generation therapies on this Master’s course. You'll acquire transferable skills in translational research, exploring the steps required to progress novel therapies from bench-to-bedside and towards drug licensing. You'll also build your knowledge of ethical and regulatory legislation, commercialisation strategies, and intellectual property and patent protection. This course is unique in providing academic and laboratory research training in three key areas of advanced therapeutic development: Gene and Nucleic Acid Based Therapies Regenerative Medicine New Horizons in Pharmacology The blended study format offers flexibility in terms of learning, with the programme delivered through a mixture of face-to-face teaching, online learning, and self-study. The MSc course allows you to pursue your speciality in greater depth, through a further advanced module and a six-month research project. You’ll also gain a basic understanding of bioinformatics and their application in biology and take part in interdisciplinary team events to generate ideas for public engagement activities, or research projects.


Entry requirements

2:1 in an appropriate subject. We also accept a wide variety of international qualifications.


Fees and funding

Tuition fees

No fee information has been provided for this course

Additional fee information

No additional fees or cost information has been supplied for this course, please contact the provider directly.
Genes, Drugs and Stem Cells – Novel Therapies at Imperial College London - UCAS